{"title":"Ecoguided ablation with foam: an alternative to the treatment of venous insufficiency in time of pandemic","authors":"Jorge Ríos","doi":"10.23736/s1593-232x.22.00523-9","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Venous insufficiency has well-defined symptoms with repercussions at the socioeconomic level. The covid pandemic decreed in March 2020 the confinement of the population, leading society to a sedentary lifestyle and weight gain, with aggravation of venous symptoms. Objective(s): To treat patients who did not respond to medical treatment in times of covid, with echo-guided foam ablation of the lesser saphenous vein. METHOD(S): It is an observational, prospective and intervention study. Patients were studied from June to September 2020. Inclusion criteria: all patients who presented symptoms and who presented reflux in the small saphenous vein during the venous Doppler study, greater than 0.5 s and a diameter greater than 4 mm and less than 7 mm. Exclusion criteria: patients who refused to participate in the study, presence of insufficiency of the great saphenous vein with transfer of reflux to the system of the small saphenous vein and those who had an ABI<0.8. RESULT(S): Four hundred patients were studied, 74% were women, with an average age of 57.6. The insufficiency of the lesser saphenous vein was found in 122 (29%), 68% were female;14.7% of the patients did not respond to treatment, and ultrasound-guided sclerosis was performed with foam. At seven days control, 83.3% of patients had the lesser saphenous vein occluded;at fourteen days, 93% of patients had the vein occluded;and 73.3% had the vein with total occlusion at one-year ultrasound control. CONCLUSION(S): Athermal ablation has been found to be a good method for treating small saphenous vein insufficiency, it can be performed in the office without complications. Copyright © 2022 EDIZIONI MINERVA MEDICA.","PeriodicalId":41673,"journal":{"name":"Acta Phlebologica","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Phlebologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s1593-232x.22.00523-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
泡沫生态引导消融:在疫情期间治疗静脉功能不全的替代方案
背景:静脉功能不全有明确的症状,并在社会经济层面产生影响。新冠肺炎疫情于2020年3月下令限制人口,导致社会养成久坐不动的生活方式,体重增加,静脉症状加重。目的:应用超声引导下小隐静脉泡沫消融治疗新冠肺炎时代对药物治疗无效的患者。方法:这是一项观察性、前瞻性和干预性研究。患者于2020年6月至9月接受研究。纳入标准:所有在静脉多普勒研究中出现症状并在小隐静脉出现反流的患者,时间大于0.5 s,直径大于4 mm且小于7 mm。排除标准:拒绝参与研究的患者,存在大隐静脉功能不全并将回流转移到小隐静脉系统的患者以及ABI<0.8的患者。结果(S):研究了400名患者,其中74%为女性,平均年龄57.6岁。小隐静脉功能不全122例(29%),女性占68%;14.7%的患者对治疗没有反应,超声引导下使用泡沫进行硬化。对照组7天时,83.3%的患者小隐静脉闭塞;14天时,93%的患者静脉闭塞;超声对照一年,73.3%的患者静脉完全闭塞。结论(S):动脉粥样硬化消融是治疗小隐静脉功能不全的一种良好方法,可在办公室进行,无并发症。版权所有©2022 EDIZIONI MINERVA MEDICA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。